Content about Bob Jones

November 15, 2012

ReportersNotebook — Over the Counter, 11/19/12

Acura Pharmaceuticals in December will launch an immediate-release pseudoephedrine tablet under the brand name Nexafed that will help impede conversion of the tablets into methamphetamine.

November 8, 2012

Acura Pharmaceuticals moves forward with plans to launch diversion-hindering PSE product

Acura Pharmaceuticals on Wednesday shared with analysts details on its launch strategy of Nexafed, a pseudoephedrine formulated such that in inhibits the diversion to methamphetamnine.

October 29, 2012

Acura Pharmaceuticals introduces PSE product that will be less attractive to 'meth cooks'

Acura Pharmaceuticals in December will launch an immediate-release pseudoephedrine tablet under the brand name Nexafed that will help impede conversion of the tablets into methamphetamine.

January 24, 2012

Oxecta now commercially available

A pain medication that utilizes Acura Pharmaceuticals' Aversion technology now is commercially available.